Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ENDRA Life Sciences Inc.

TRADE

NASDAQ: NDRA / / -
2.09-0.05-2.34%Vol 22 0761Y Perf -39.71%
Jul 20th, 2018 15:59
BID2.07 ASK2.10
Open2.19 Previous Close2.14
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Neutral
Price Range Ratio 52wk %
12.47 
Earnings Date
6th Aug 2018

Today's Price Range

2.052.19

 

52wk Range

1.555.88

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-16.73%
3 Months
-16.40%
6 Months
-22.88%
1 Year
-39.71%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
NDRA2.09-0.0500-2.34
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.70
Current Ratio 4.00
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage 3 685.30
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin51.70
EBIT Margin-1 985.20
EBITDA Margin-1 968.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.07
PS Ratios 28.96
Price to Cash Flow -
Price to Free Cash Flow -2.00
Cash Flow Per Share -1.41
Price to Tangible Book3.07
Book Value per Share0.72
Enterprise Value (in ths.)5 540
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -1 028.93
Return on Assets (5Y Avg) -
ROA last 12 Months -352.32
Return on Capital (5Y Avg) -
ROC last 12 Months -1 028.93
Return on invested Capital Q -69.71
Return on invested Capital Y-245.43
Assets Turnover0.00
Receivables Turnover51.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)300
Revenue per Share 0.08
Revenue Growth 3 Years -36.86
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume22 076
Shares Outstanding (in ths.)3 920
Trades Count50
Dollar Volume41 001
Avg. Volume60 970
Avg. Weekly Volume129 221
Avg. Monthly Volume98 695
Avg. Quarterly Volume114 554

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

29%71%

Bearish Bullish

58%42%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x